Inventor · disambiguated record
Rama Jain
Also filed as: JAIN RAMA
14 granted patents·12 pending applications·54 citations·filing 2005–2024
89Inventor score
Top patents by PatentIndex Score
26 records- 0192US11098051B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Aug 24, 2021·5 cites·19 claims
- 0292US10160764B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 25, 2018·11 cites·29 claims
- 0391US11453677B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2020·Granted Sep 27, 2022·2 cites·14 claims
- 0489US7932262B2Quinazolines for PDK1 inhibitionNOVARTIS AG·Filed 2007·Granted Apr 26, 2011·24 cites·24 claims
- 0585US7576221B2Substituted imidazole derivativesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Aug 18, 2009·5 cites·18 claims
- 0684US2025011334A1Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0783US12252482B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2024·Granted Mar 18, 2025·0 cites·22 claims
- 0882US11629149B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 0982US2025282762A1Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1081US10858366B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 8, 2020·3 cites·20 claims
- 1179US12172984B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1277US2025034156A110-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating InfluenzaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1374US12071441B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 1473US11912715B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 1573US11787785B2Pyrazolopyridine derivatives and uses thereofNOVARTIS AG·Filed 2022·Granted Oct 17, 2023·0 cites·15 claims
- 1673US8318791B2Substituted imidazole derivativesWANG WEIBO·Filed 2009·Granted Nov 27, 2012·1 cites·20 claims
- 1757US8735599B2Substituted imidazole derivatesWANG WEIBO·Filed 2012·Granted May 27, 2014·0 cites·11 claims
- 1856US2025276964A1Benzisoxazole Derivatives and Uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1951US2010121052A1Novel compounds for treating proliferative diseasesJAIN RAMA·Filed 2009·Application pending·0 cites
- 2049US2008262056A1Oxindole Oxazolidinones as Antibacterial AgentsPFIZER·Filed 2005·Application pending·0 cites
- 2149US2022363671A1Glue degraders and methods of use thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2245US2010216767A1Quinazolines for pdk1 inhibitionAIKAWA MINA·Filed 2007·Application pending·0 cites
- 2345US2020407365A1Indole-2-carbonyl compounds and their use for the treatment of hepatitis bNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2444US2006030609A1Oxazolidinones containing oxindoles as antibacterial agentsLUEHR GARY W·Filed 2005·Application pending·0 cites
- 2538US2006035932A1N-aryl piperidine compoundsPROPHARMACON INC·Filed 2005·Application pending·0 cites
- 2636US2009143411A1Thiophens and Their Use as Anti-Tumor AgentsCOMPASS PHARMACEUTICALS LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rama Jain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →